デフォルト表紙
市場調査レポート
商品コード
1513201

眼炎症治療の世界市場レポート 2024年

Ocular Inflammation Treatment Global Market Report 2024

出版日: | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.54円
眼炎症治療の世界市場レポート 2024年
出版日: 2024年07月15日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

眼炎症治療の市場規模は、今後数年間で力強い成長が見込まれます。2028年の年間平均成長率(CAGR)は6.1%で、118億8,000万米ドルに成長します。予測期間中に予想される成長は、生物製剤や標的治療薬に対する需要の高まり、早期診断と介入の重視、ヘルスケア支出の増加、眼科医療へのアクセスの拡大、遠隔眼科ソリューションの採用拡大、新規治療に対する規制当局の支援など、いくつかの要因に起因しています。予測期間中に予想される主な動向には、生物学的治療へのシフト、ドラッグデリバリーの進歩、個別化医療へのアプローチ、遠隔眼科の統合、安全性と有効性の規制重視、治療選択肢の拡大などがあります。

高齢者の割合の増加が眼炎症治療市場の成長を刺激すると予想されます。加齢は、段階的な生理的低下と組織の完全性喪失を特徴とする自然なプロセスであり、ヘルスケアの向上、出生率の低下、平均寿命の延長などの要因により増加傾向にあります。高齢化社会が拡大するにつれ、加齢に伴う炎症関連症状から視力を管理・保護する眼炎症治療の需要が高まっています。例えば、世界保健機関(WHO)の報告書によると、60歳以上の人口は2020年の10億人から2022年には14億人と大幅に増加し、2030年には世界の6人に1人が60歳以上になると予測されています。その結果、高齢化の進展が眼炎症治療市場を促進することになります。

眼炎症治療分野の有力企業は、自己乳化型ドラッグデリバリーシステム(SEDDS)技術などの先端技術を点眼薬に統合することに注力しています。この統合は、薬物の吸収を高め、治療効果を拡大し、患者の利便性を向上させることを目的としています。点眼薬におけるSEDDS技術は、治療薬のバイオアベイラビリティと眼への吸収性を高め、様々な眼疾患に対してより効果的な治療結果を約束します。例えば、ENTOD Pharmaceuticals社は2023年5月、炎症性ドライアイの患者をターゲットとしたCYCLOTEARS点眼薬を発売しました。CYCLOTEARSは、科学産業研究省(DSIR)の承認を受けたインドの科学者によって開発された、同社独自のSEDDS技術を搭載した世界初のドライアイ治療薬として際立っています。この技術の開発には、インド各地の著名な眼科研究機関との協力が役立っています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の眼炎症治療市場:促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の眼炎症治療市場の実績:規模と成長, 2018-2023
  • 世界の眼炎症治療市場の予測:規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

  • 世界の眼炎症治療市場:治療タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 免疫抑制剤
  • 抗ウイルス薬
  • コルチコステロイド
  • 抗生物質
  • 鎮痛剤
  • モノクローナル抗体
  • 抗真菌
  • 毛様体麻痺
  • 世界の眼炎症治療市場:オペレーション方式別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 注射剤
  • 経口
  • 外用
  • その他の動作モード
  • 世界の眼炎症治療市場:疾患タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 前部ぶどう膜炎
  • 中間ぶどう膜炎
  • 強膜炎
  • 後部ぶどう膜炎
  • ぶどう膜炎
  • 世界の眼炎症治療市場:流通チャネル別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 小売薬局
  • オンライン薬局
  • 病院薬局
  • ドラッグストア

第7章 地域別・国別分析

  • 世界の眼炎症治療市場:地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 世界の眼炎症治療市場:国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 眼炎症治療市場:競合情勢
  • 眼炎症治療市場:企業プロファイル
    • Pfizer Inc.
    • Johnson & Johnson Services Inc.
    • F. Hoffmann-La Roche Ltd.
    • Merck & Co. Inc.
    • AbbVie Inc.

第31章 その他の大手企業と革新的企業

  • Novartis AG
  • GlaxoSmithKline plc
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Regeneron Pharmaceuticals Inc.
  • Mylan N.V.
  • Bristol Myers Squibb Company
  • Alcon Laboratories Inc.
  • Bausch Health Companies Inc.
  • Macleods Pharmaceuticals Ltd
  • Intas Pharmaceuticals Ltd
  • Cipla Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Mallinckrodt Pharmaceuticals
  • Akron Pharma Inc

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r18188

Ocular inflammation treatment involves medical interventions aimed at reducing swelling and safeguarding the eyes from damage caused by inflammation, ensuring clear vision and eye health. Typically, treatment for ocular inflammation encompasses medication, eye drops, and occasionally additional therapies, tailored to the severity and underlying cause of the inflammation.

The primary types of ocular inflammation treatment include immunosuppressants, antivirals, corticosteroids, antibiotics, analgesics, monoclonal antibodies, antifungals, and cycloplegics. Immunosuppressants are medications designed to diminish the activity of the body's immune system, thereby aiding in controlling inflammation in the eyes. These treatment modalities are administered via injectables, orals, topicals, and other routes, targeting disease types such as anterior uveitis, intermediate uveitis, episcleritis/scleritis, posterior uveitis, and panuveitis. The distribution channels for these treatment products include retail pharmacies, online pharmacies, hospital pharmacies, and drug stores.

The ocular inflammation treatment market research report is one of a series of new reports from The Business Research Company that provides ocular inflammation treatment market statistics, including ocular inflammation treatment industry global market size, regional shares, competitors with a ocular inflammation treatment market share, detailed ocular inflammation treatment market segments, market trends and opportunities, and any further data you may need to thrive in the ocular inflammation treatment industry. This ocular inflammation treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ocular inflammation treatment market size has grown strongly in recent years. It will grow from $8.85 billion in 2023 to $9.38 billion in 2024 at a compound annual growth rate (CAGR) of 6%. The growth observed during the historic period can be attributed to several factors, including advancements in ophthalmic research, an increased incidence of ocular inflammatory conditions, a growing aging population, the expansion of healthcare infrastructure, rising awareness about eye health, innovation in treatment modalities, and the development of novel therapeutics.

The ocular inflammation treatment market size is expected to see strong growth in the next few years. It will grow to $11.88 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The anticipated growth in the forecast period can be attributed to several factors, including the rising demand for biologics and targeted therapies, an emphasis on early diagnosis and intervention, increasing healthcare expenditure, expanding access to ophthalmic care, growing adoption of teleophthalmology solutions, and regulatory support for novel treatments. Major trends expected in the forecast period include a shift towards biologic therapies, advancements in drug delivery, personalized medicine approaches, integration of teleophthalmology, regulatory emphasis on safety and efficacy, and expansion of therapeutic options.

The increasing proportion of elderly individuals is anticipated to stimulate growth in the ocular inflammation treatment market. Aging, a natural process characterized by gradual physiological decline and tissue integrity loss, is on the rise due to factors such as improved healthcare, declining birth rates, and increased life expectancy. As the aging population expands, the demand for ocular inflammation treatment rises to manage and safeguard vision against age-related inflammation-related conditions. For instance, a report from the World Health Organization projected a significant increase in the demographic of individuals aged 60 and above, from 1 billion in 2020 to 1.4 billion by 2022, with estimates suggesting that one out of every six individuals globally will be aged 60 or older by 2030. Consequently, the aging population's growth will propel the ocular inflammation treatment market.

Prominent players in the ocular inflammation treatment sector are concentrating on integrating advanced technologies, such as self-emulsifying drug delivery system (SEDDS) technology, into eye drops. This integration aims to enhance drug absorption, extend therapeutic effects, and improve patient convenience. SEDDS technology in eye drops enhances bioavailability and ocular absorption of therapeutic agents, promising more effective treatment outcomes for various ocular conditions. For example, ENTOD Pharmaceuticals launched CYCLOTEARS eye drops in May 2023, targeting patients with inflammatory dry eye disease, a prevalent condition. CYCLOTEARS stands out as the world's first dry eye therapy to feature the company's proprietary SEDDS technology, developed by Indian scientists endorsed by the Department of Scientific and Industrial Research (DSIR). Collaborations with esteemed eye research institutes across India have been instrumental in the technology's development.

In June 2023, Bausch + Lomb acquired eye care products from Novartis AG for $1.75 billion, strategically strengthening its presence in the dry eye disease market segment. This acquisition, featuring Xiidra as a key asset, enhances Bausch + Lomb's ability to address the prevalent condition affecting millions globally. Novartis AG, a Swiss pharmaceutical corporation, specializes in producing drugs for ocular inflammation treatment.

Major companies operating in the ocular inflammation treatment market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, GlaxoSmithKline plc, Amgen Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Bristol Myers Squibb Company, Alcon Laboratories Inc., Bausch Health Companies Inc., Macleods Pharmaceuticals Ltd, Intas Pharmaceuticals Ltd, Cipla Inc., Santen Pharmaceutical Co. Ltd., Mallinckrodt Pharmaceuticals, Akron Pharma Inc, Sun Pharmaceutical Industries Ltd., Alimera Sciences, Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Tarsier Pharma, Graybug Vision Inc., EyeGate, Oculis S.A.

North America was the largest region in the ocular inflammation treatment market in 2023. The regions covered in the ocular inflammation treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ocular inflammation treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ocular inflammation treatment market consists of revenues earned by entities by providing services such as diagnostic services, treatment administration services, patient support programs, telemedicine, and remote monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The ocular inflammation treatment market also includes sales of long-acting corticosteroid implants, contact lenses, compounded medications, and biodegradable inserts. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ocular Inflammation Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ocular inflammation treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ocular inflammation treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ocular inflammation treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Treatment Type: Immunosuppressant; Antivirals; Corticosteroids; Antibiotics; Analgesics; Monoclonal Antibodies; Antifungal; Cycloplegic
  • 2) By Mode of Operation: Injectables; Oral; Topical; Other Modes Of Operation
  • 3) By Disease Type: Anterior Uveitis; Intermediate Uveitis; Episcleritis/Scleritis; Posterior Uveitis; Panuveitis
  • 4) By Distribution Channel: Retail Pharmacies; Online Pharmacies; Hospital Pharmacies; Drug Stores
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ocular Inflammation Treatment Market Characteristics

3. Ocular Inflammation Treatment Market Trends And Strategies

4. Ocular Inflammation Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Ocular Inflammation Treatment Market Size and Growth

  • 5.1. Global Ocular Inflammation Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Ocular Inflammation Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Ocular Inflammation Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Ocular Inflammation Treatment Market Segmentation

  • 6.1. Global Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Immunosuppressant
  • Antivirals
  • Corticosteroids
  • Antibiotics
  • Analgesics
  • Monoclonal Antibodies
  • Antifungal
  • Cycloplegic
  • 6.2. Global Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Injectables
  • Oral
  • Topical
  • Other Modes Of Operation
  • 6.3. Global Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Anterior Uveitis
  • Intermediate Uveitis
  • Episcleritis/Scleritis
  • Posterior Uveitis
  • Panuveitis
  • 6.4. Global Ocular Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
  • Drug Stores

7. Ocular Inflammation Treatment Market Regional And Country Analysis

  • 7.1. Global Ocular Inflammation Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Ocular Inflammation Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Ocular Inflammation Treatment Market

  • 8.1. Asia-Pacific Ocular Inflammation Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Ocular Inflammation Treatment Market

  • 9.1. China Ocular Inflammation Treatment Market Overview
  • 9.2. China Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Ocular Inflammation Treatment Market

  • 10.1. India Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Ocular Inflammation Treatment Market

  • 11.1. Japan Ocular Inflammation Treatment Market Overview
  • 11.2. Japan Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Ocular Inflammation Treatment Market

  • 12.1. Australia Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Ocular Inflammation Treatment Market

  • 13.1. Indonesia Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Ocular Inflammation Treatment Market

  • 14.1. South Korea Ocular Inflammation Treatment Market Overview
  • 14.2. South Korea Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Ocular Inflammation Treatment Market

  • 15.1. Western Europe Ocular Inflammation Treatment Market Overview
  • 15.2. Western Europe Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Ocular Inflammation Treatment Market

  • 16.1. UK Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Ocular Inflammation Treatment Market

  • 17.1. Germany Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Ocular Inflammation Treatment Market

  • 18.1. France Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Ocular Inflammation Treatment Market

  • 19.1. Italy Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Ocular Inflammation Treatment Market

  • 20.1. Spain Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Ocular Inflammation Treatment Market

  • 21.1. Eastern Europe Ocular Inflammation Treatment Market Overview
  • 21.2. Eastern Europe Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Ocular Inflammation Treatment Market

  • 22.1. Russia Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Ocular Inflammation Treatment Market

  • 23.1. North America Ocular Inflammation Treatment Market Overview
  • 23.2. North America Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Ocular Inflammation Treatment Market

  • 24.1. USA Ocular Inflammation Treatment Market Overview
  • 24.2. USA Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Ocular Inflammation Treatment Market

  • 25.1. Canada Ocular Inflammation Treatment Market Overview
  • 25.2. Canada Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Ocular Inflammation Treatment Market

  • 26.1. South America Ocular Inflammation Treatment Market Overview
  • 26.2. South America Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Ocular Inflammation Treatment Market

  • 27.1. Brazil Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Ocular Inflammation Treatment Market

  • 28.1. Middle East Ocular Inflammation Treatment Market Overview
  • 28.2. Middle East Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Ocular Inflammation Treatment Market

  • 29.1. Africa Ocular Inflammation Treatment Market Overview
  • 29.2. Africa Ocular Inflammation Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Ocular Inflammation Treatment Market, Segmentation By Mode of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Ocular Inflammation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Ocular Inflammation Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Ocular Inflammation Treatment Market Competitive Landscape
  • 30.2. Ocular Inflammation Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson Services Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. F. Hoffmann-La Roche Ltd.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck & Co. Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. AbbVie Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Ocular Inflammation Treatment Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. GlaxoSmithKline plc
  • 31.3. Amgen Inc.
  • 31.4. Teva Pharmaceutical Industries Ltd.
  • 31.5. Regeneron Pharmaceuticals Inc.
  • 31.6. Mylan N.V.
  • 31.7. Bristol Myers Squibb Company
  • 31.8. Alcon Laboratories Inc.
  • 31.9. Bausch Health Companies Inc.
  • 31.10. Macleods Pharmaceuticals Ltd
  • 31.11. Intas Pharmaceuticals Ltd
  • 31.12. Cipla Inc.
  • 31.13. Santen Pharmaceutical Co. Ltd.
  • 31.14. Mallinckrodt Pharmaceuticals
  • 31.15. Akron Pharma Inc

32. Global Ocular Inflammation Treatment Market Competitive Benchmarking

33. Global Ocular Inflammation Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Ocular Inflammation Treatment Market

35. Ocular Inflammation Treatment Market Future Outlook and Potential Analysis

  • 35.1 Ocular Inflammation Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Ocular Inflammation Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Ocular Inflammation Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer